Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Net Income: 2023-2025

Historic Net Income for Camp4 Therapeutics (CAMP) over the last 2 years, with Sep 2025 value amounting to -$13.2 million.

  • Camp4 Therapeutics' Net Income rose 1.90% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 0.41%. This contributed to the annual value of -$51.8 million for FY2024, which is 5.07% down from last year.
  • Per Camp4 Therapeutics' latest filing, its Net Income stood at -$13.2 million for Q3 2025, which was down 5.19% from -$12.6 million recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Net Income high stood at -$11.7 million for Q3 2023, and its period low was -$13.5 million during Q3 2024.
  • Moreover, its 3-year median value for Net Income was -$12.6 million (2025), whereas its average is -$12.7 million.
  • Its Net Income has fluctuated over the past 5 years, first decreased by 15.29% in 2024, then climbed by 1.90% in 2025.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' Net Income stood at -$13.0 million in 2023, then decreased by 2.22% to -$13.3 million in 2024, then increased by 1.90% to -$13.2 million in 2025.
  • Its last three reported values are -$13.2 million in Q3 2025, -$12.6 million for Q2 2025, and -$12.5 million during Q1 2025.